Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Probtec is a biotechnology company based in Greece that specializes in the research, development, and production of high-quality probiotic strains for the pharmaceutical, nutraceutical, and food industries. The company operates a state-of-the-art manufacturing facility and utilizes a proprietary platform for the isolation and characterization of microbial strains with specific health benefits. Probtec's expertise spans the entire value chain, from strain selection and fermentation to stabilization and final product formulation. Their portfolio includes clinically documented strains of Lactobacillus and Bifidobacterium targeting gastrointestinal health, immune support, and metabolic wellness. As a B2B provider, Probtec offers custom strain development and contract manufacturing services to global partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Probtec.